Doi R - Search Results

1

Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.

Mori T, Doi R, Kida A, Nagai K, Kami K, Ito D, Toyoda E, Kawaguchi Y, Uemoto S. Mori T, et al. Among authors: doi r. J Surg Res. 2007 Oct;142(2):281-6. doi: 10.1016/j.jss.2007.03.068. Epub 2007 Jul 19. J Surg Res. 2007. PMID: 17640673

2

Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.

Mori T, Doi R, Toyoda E, Koizumi M, Ito D, Kami K, Kida A, Masui T, Kawaguchi Y, Fujimoto K. Mori T, et al. Among authors: doi r. Surgery. 2005 Jul;138(1):71-7. doi: 10.1016/j.surg.2005.03.001. Surgery. 2005. PMID: 16003319

3

Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.

Kami K, Doi R, Koizumi M, Toyoda E, Mori T, Ito D, Kawaguchi Y, Fujimoto K, Wada M, Miyatake S, Imamura M. Kami K, et al. Among authors: doi r. Surgery. 2005 Aug;138(2):299-305. doi: 10.1016/j.surg.2005.05.009. Surgery. 2005. PMID: 16153440

4

Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.

Masui T, Hosotani R, Ito D, Kami K, Koizumi M, Mori T, Toyoda E, Nakajima S, Miyamoto Y, Fujimoto K, Doi R. Masui T, et al. Among authors: doi r. Surgery. 2006 Aug;140(2):149-60. doi: 10.1016/j.surg.2006.03.014. Surgery. 2006. PMID: 16904964

5

Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.

Toyoda E, Doi R, Kami K, Mori T, Ito D, Koizumi M, Kida A, Nagai K, Ito T, Masui T, Wada M, Tagawa M, Uemoto S. Toyoda E, et al. Among authors: doi r. J Exp Clin Cancer Res. 2008 Aug 21;27(1):30. doi: 10.1186/1756-9966-27-30. J Exp Clin Cancer Res. 2008. PMID: 18717994 Free PMC article.

6

All-trans retinoic acid induces differentiation of ducts and endocrine cells by mesenchymal/epithelial interactions in embryonic pancreas.

Tulachan SS, Doi R, Kawaguchi Y, Tsuji S, Nakajima S, Masui T, Koizumi M, Toyoda E, Mori T, Ito D, Kami K, Fujimoto K, Imamura M. Tulachan SS, et al. Among authors: doi r. Diabetes. 2003 Jan;52(1):76-84. doi: 10.2337/diabetes.52.1.76. Diabetes. 2003. PMID: 12502496

7

RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.

Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, Kami K, Mori T, Wada M, Noda M, Imamura M. Masui T, et al. Among authors: doi r. Clin Cancer Res. 2003 May;9(5):1779-84. Clin Cancer Res. 2003. PMID: 12738734

8

Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.

Tsuji S, Hosotani R, Yonehara S, Masui T, Tulachan SS, Nakajima S, Kobayashi H, Koizumi M, Toyoda E, Ito D, Kami K, Mori T, Fujimoto K, Doi R, Imamura M. Tsuji S, et al. Among authors: doi r. Int J Cancer. 2003 Aug 10;106(1):17-25. doi: 10.1002/ijc.11170. Int J Cancer. 2003. PMID: 12794752

9

Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer.

Koizumi M, Doi R, Toyoda E, Masui T, Tulachan SS, Kawaguchi Y, Fujimoto K, Gittes GK, Imamura M. Koizumi M, et al. Among authors: doi r. Surgery. 2003 Aug;134(2):260-6. doi: 10.1067/msy.2003.231. Surgery. 2003. PMID: 12947327

10

CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer.

Mori T, Doi R, Koizumi M, Toyoda E, Ito D, Kami K, Masui T, Fujimoto K, Tamamura H, Hiramatsu K, Fujii N, Imamura M. Mori T, et al. Among authors: doi r. Mol Cancer Ther. 2004 Jan;3(1):29-37. Mol Cancer Ther. 2004. PMID: 14749473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

655 results

Search Page

Filters